All patients | FVC ≤ 50% predicted only | DLco ≤ 30% predicted only | Both FVC ≤ 50% and DLco ≤ 30% predicted | p-value | |
---|---|---|---|---|---|
Patients, n (%) | 242 | 95 (39%) | 94 (39%) | 53 (22%) | |
Male, n (%) | 196 (81%) | 74 (78%) | 79 (84%) | 43 (81%) | 0.08 |
Age, years ± SD | 72 ± 8 | 72 ± 8† | 73 ± 8*§ | 71 ± 7† | 0.01 |
BMI, mean ± SD | 28 ± 5 | 27 ± 5 | 27 ± 5 | 31 ± 6 | 0.15 |
Smokers, n, % (mean PY ± SD) | 155, 68% (30 ± 23) | 54, 60%† (22 ± 20) | 69, 73%* (34 ± 25) | 32, 60% (32 ± 21) | 0.02 |
FVC% ± SD | 53 ± 17 | 42 ± 7 | 70 ± 17 | 43 ± 5 | |
DLco% ± SD | 28 ± 9 | 39 ± 9 | 24 ± 4 | 24 ± 6 | |
Available 6MWT, n (%) | 231 (95%) | 91 (99%) | 92 (98%) | 48 (91%) | |
6MWD, meters ± SD | 304 ± 121 | 309 ± 123 | 319 ± 117§ | 266 ± 116† | 0.04 |
\({\text{6MWT}}_{{{\text{O}}_{{2}} }}\), n (%) | 140 (59%) | 50 (54%) | 53 (56%) | 37 (70%) | 0.08 |
\({\text{6MWT}}_{{{\text{O}}_{{2}} }}\) mean flow rate, L/min | 5 | 4 | 5 | 5 | |
6MWT SpO2 nadir, % ± SD | 88 ± 5 | 89 ± 5 | 88 ± 6 | 88 ± 5 | 0.51 |
6MWT max Borg, mean ± SD | 4 ± 2 | 4 ± 2 | 4 ± 2 | 4 ± 2 | 0.29 |